Found 6 matching trials
NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
PHASE2This clinical trial aims to evaluate the effectiveness of a new treatment a...
Location
Oslo University Hospital
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
PHASE1The study will assess the safety, tolerability, PK and efficacy of differen...
Location
Jules Bordet Institute
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma
PHASE2ATLAS-IT-05 is an open-label, single-arm study in patients with advanced me...
Location
Icahn School of Medicine at Mount Sinai
LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)
PHASE2ATLAS-IT-04 is a two part, single arm study designed to determine the safet...
A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma
PHASE1This study involves testing of the medicine LTX-315 combined with a cancer ...
Location
University Hospital North-Norway
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
PHASE1The study will evaluate the safety profile for LTX-315 a lytic-peptide that...
Location
Oslo University Hospital, Radiumhospitalet